Publications by authors named "Tomas Ahlgren"

Claim this Profile
T
Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas.
Eva Kimby, Björn Östenstad, Peter Brown, Hans Hagberg, Martin Erlanson, Tomas Ahlgren

Leuk Lymphoma· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Anders Wahlin, Rolf Billström, Ove Björ, Tomas Ahlgren, Michael Hedenus

Eur J Haematol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell precursor t(8;14)(q11;q32)-positive acute lymphoblastic leukemia in children is strongly associated with Down syndrome or with a concomitant Philadelphia chromosome.
Catarina Lundin, Jesper Heldrup, Tomas Ahlgren, Tor Olofsson, Bertil Johansson

Eur J Haematol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of busulphan, hydroxyurea and allogeneic bone marrow transplantation (BMT) in chronic myeloid leukaemia: BMT prolongs survival.
Ulla Olsson-Strömberg, Bengt Simonsson, Tomas Ahlgren, Magnus Björkholm, Karin Carlsson

Hematol J· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies.
Clelia T Storlazzi, Thoas Fioretos, Kajsa Paulsson, Bodil Strömbeck, Carin Lassen, Tomas Ahlgren

Hum Mol Genet· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic and morphologic subgroups of myelodysplastic syndromes in relation to occupational and hobby exposures.
Maria Albin, Jonas Björk, Hans Welinder, Håkan Tinnerberg, Nils Mauritzson, Tomas Ahlgren

Scand J Work Environ Health· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic studies of ETV6/ABL1-positive chronic myeloid leukaemia in blast crisis treated with imatinib mesylate.
Aikaterini Barbouti, Tomas Ahlgren, Bertil Johansson, Mattias Höglund, Carin Lassen

Br J Haematol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.
Eva Hellström-Lindberg, Nina Gulbrandsen, Greger Lindberg, Tomas Ahlgren, Inger Marie S Dahl

Br J Haematol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis